These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23882694)

  • 1. Anti-retinal antibodies in patients with macular telangiectasia type 2.
    Zhu L; Shen W; Zhu M; Coorey NJ; Nguyen AP; Barthelmes D; Gillies MC
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5675-83. PubMed ID: 23882694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-retinal IgG antibodies in patients with early and advanced type 2 macular telangiectasia.
    McLenachan S; Balaratnasingam C; Heath Jeffery RC; Chen SC; Zhang D; Chan G; Dolz-Marco R; Bacci T; Lo J; Wiffen S; Yannuzzi LA; Chen FK
    Exp Eye Res; 2022 May; 218():109024. PubMed ID: 35271830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demographic features of idiopathic macular telangiectasia in Korean patients.
    Kim SH; Oh J; Ahn SE; Park CY; Oh JH
    Korean J Ophthalmol; 2015 Jun; 29(3):155-9. PubMed ID: 26028942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of anti-retinal antibodies in patients with age-related macular degeneration.
    Morohoshi K; Ohbayashi M; Patel N; Chong V; Bird AC; Ono SJ
    Exp Mol Pathol; 2012 Oct; 93(2):193-9. PubMed ID: 22465421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cell-mediated immune response against human retinal antigens in relation to ocular onchocerciasis.
    Van der Lelij A; Rothova A; Stilma JS; Vetter JC; Hoekzema R; Kijlstra A
    Acta Leiden; 1990; 59(1-2):271-83. PubMed ID: 2378211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
    Adamus G; Ren G; Weleber RG
    BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical characteristics of patients with macular telangiectasia type 2 (MacTel Type 2) MacTel project report no. 3.
    Clemons TE; Gillies MC; Chew EY; Bird AC; Peto T; Wang JJ; Mitchell P; Ramdas WD; Vingerling JR;
    Ophthalmic Epidemiol; 2013 Apr; 20(2):109-13. PubMed ID: 23510315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis).
    Umeda S; Suzuki MT; Okamoto H; Ono F; Mizota A; Terao K; Yoshikawa Y; Tanaka Y; Iwata T
    FASEB J; 2005 Oct; 19(12):1683-5. PubMed ID: 16099945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outer retinal hyperreflective spots on spectral-domain optical coherence tomography in macular telangiectasia type 2.
    Baumüller S; Charbel Issa P; Scholl HP; Schmitz-Valckenberg S; Holz FG
    Ophthalmology; 2010 Nov; 117(11):2162-8. PubMed ID: 20557944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The longitudinal impact of macular telangiectasia (MacTel) type 2 on vision-related quality of life.
    Lamoureux EL; Maxwell RM; Marella M; Dirani M; Fenwick E; Guymer RH
    Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2520-4. PubMed ID: 21217104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating anti-retinal antibodies as immune markers in age-related macular degeneration.
    Patel N; Ohbayashi M; Nugent AK; Ramchand K; Toda M; Chau KY; Bunce C; Webster A; Bird AC; Ono SJ; Chong V
    Immunology; 2005 Jul; 115(3):422-30. PubMed ID: 15946260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States.
    Grus FH; Joachim SC; Bruns K; Lackner KJ; Pfeiffer N; Wax MB
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):968-76. PubMed ID: 16505031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of type 2 idiopathic macular telangiectasia in two African populations.
    Sallo FB; Leung I; Mathenge W; Kyari F; Kuper H; Gilbert CE; Bird AC; Peto T;
    Ophthalmic Epidemiol; 2012 Aug; 19(4):185-9. PubMed ID: 22364548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against human retinal proteins in serum from patients with cone dystrophy.
    Isashiki Y; Ohba N; Nakagawa M; Miyake Y
    Jpn J Ophthalmol; 1992; 36(3):323-30. PubMed ID: 1464972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia.
    Wolf-Schnurrbusch UEK; Leung I; Sallo FB; Clemons TE; Chew EY; Bird AC; Peto T;
    Ophthalmic Res; 2018; 60(1):38-42. PubMed ID: 28903123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Takayama K; Arakawa N; Tsujikawa A; Koizumi H; Oshima S; Yoshimura N
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5541-50. PubMed ID: 21642620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of autoantibodies against human retinal antigens in sera of patients with glaucoma and ocular hypertension.
    Reichelt J; Joachim SC; Pfeiffer N; Grus FH
    Curr Eye Res; 2008 Mar; 33(3):253-61. PubMed ID: 18350436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of anti-retinal antibodies in normal human serum.
    Shimazaki K; Jirawuthiworavong GV; Heckenlively JR; Gordon LK
    J Neuroophthalmol; 2008 Mar; 28(1):5-11. PubMed ID: 18347451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization.
    Morohoshi K; Patel N; Ohbayashi M; Chong V; Grossniklaus HE; Bird AC; Ono SJ
    Exp Mol Pathol; 2012 Feb; 92(1):64-73. PubMed ID: 22001380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis.
    Degli Esposti S; Egan C; Bunce C; Moreland JD; Bird AC; Robson AG
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6568-75. PubMed ID: 22899764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.